Coronavirus pandemic: treatment and future prevention
Related Experiment Video
Updated: Dec 2, 2025
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
1PanTherapeutics, Rte de Lavaux 49, 1095 Lutry, Switzerland.
Abstract:
The rapid spread of SARS-CoV-2 leading to the COVID-19 pandemic with more than 400,000 deaths worldwide and the global economy shut down has substantially accelerated the research and development of novel and efficient COVID-19 antiviral drugs and vaccines. In the short term, antiviral and other drugs have been subjected to repurposing against COVID-19 demonstrating some success, but some excessively hasty conclusions drawn from significantly suboptimal clinical evaluations have provided false hope. On the other hand, more than 300 potential therapies and at least 150 vaccine studies are in progress at various stages of preclinical or clinical research. The aim here is to provide a timely update of the development, which, due to the intense activities, moves forward with unprecedented speed.
Insights
The COVID-19 pandemic spurred rapid development of antiviral drugs and vaccines. While some repurposed drugs showed promise, ongoing research into over 300 therapies and 150 vaccines offers significant hope for effective treatments.
Area of Science:
- Virology
- Infectious Diseases
- Drug Development
Background:
- The COVID-19 pandemic caused by SARS-CoV-2 has led to over 400,000 deaths globally and significant economic disruption.
- The urgent need for effective treatments has accelerated research into novel antiviral drugs and vaccines.
- Drug repurposing efforts have shown some success, but have also led to premature conclusions based on insufficient clinical data.
Purpose of the Study:
- To provide a timely update on the development of COVID-19 antiviral drugs and vaccines.
- To highlight the unprecedented speed of research and development in response to the pandemic.
Main Methods:
- Review of ongoing preclinical and clinical research for COVID-19 therapies.
- Analysis of drug repurposing initiatives and vaccine development studies.
Main Results:
- Over 300 potential therapies are under investigation.
- At least 150 vaccine studies are in various stages of research.
- Some repurposed drugs have demonstrated limited success, while others have yielded false hope due to suboptimal evaluations.
Conclusions:
- The development of COVID-19 treatments and vaccines is progressing at an unprecedented pace.
- Continued rigorous research is essential to identify safe and effective therapies and vaccines for COVID-19.
Related Concept Videos
01:28Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
01:30Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
01:28Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:30Preventive Healthcare Services
01:26Coronary Artery Disease IV: Preventive Measures
01:29Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation